Description
Triple-Agonist Power: GLP-1 + GIP + Glucagon
RTA10 is the world’s first “triple-G” agonist, targeting three distinct metabolic receptors simultaneously. While GLP-1 and GIP work to suppress appetite and optimize insulin, the addition of Glucagon is the game-changer. This third mechanism specifically targets energy expenditure, signaling the body to burn more calories at rest. This synergy creates a metabolic environment where fat loss occurs significantly faster and more efficiently than with dual-agonist therapies.
Increase Resting Metabolic Rate
The defining advantage of RTA10 over older peptides is its ability to increase Resting Energy Expenditure (REE). By activating glucagon receptors in the liver and adipose tissue, it promotes thermogenesis—literally turning up your body’s internal heat to oxidize fat stores. This means you aren’t just eating less; you are actively burning more energy every hour of the day, preventing the metabolic slowdown often associated with rapid weight loss.
Mobilize Stubborn Visceral & Liver Fat
RTA10 has shown unprecedented efficacy in targeting visceral fat, particularly in the liver. Excess liver fat is a primary driver of metabolic dysfunction and insulin resistance. By aggressively oxidizing these deep adipose depots, RTA10 doesn’t just improve your waistline; it profoundly restores metabolic health and liver function markers, addressing the root cause of weight gain rather than just the symptom.
Superior Nutrient Partitioning & Muscle Preservation
Rapid weight loss often comes at the cost of muscle tissue. RTA10’s unique mechanism helps improve nutrient partitioning—directing energy toward muscle maintenance while prioritizing fat for fuel. When combined with adequate protein intake, this supports a true “recomposition” effect, allowing users to drop significant body fat percentage while retaining the lean muscle mass essential for a healthy, sculpted physique.
Reviews
There are no reviews yet.